Despite resubmitting after an initial complete response letter (CRL) due to manufacturing issues, the combination therapy ...

(CNN)-- The controversial drug Avastin should be phased out as a treatment for metastatic breast cancer, the Food and Drug Administration said Thursday, citing recent studies that show its ...

Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.

Call your doctor right away if you have any serious side effects during treatment with Avastin. If the side effects seem life threatening or you think you’re having a medical emergency ...

The experimental therapy demonstrated a safety profile ... a six-month survival advantage with cancer drugs atezolizumab and bevacizumab, marketed as Tecentriq and Avastin by Roche (OTCQX:RHHBY ...

The combination of bevacizumab with chemotherapy has demonstrated clinical benefit for patients with advanced non-small-cell lung cancer (NSCLC), according to a large, international, randomized ...

Amgen and Allergan’s biosimilar of Roche’s cancer blockbuster Avastin has been approved in the EU, but there could be a four-year wait before the drug makes it to the market. The patent ...

Tecentriq in combination with bevacizumab will help the 70 or so New Zealanders diagnosed with Hepatocellular Carcinoma (HCC) each year.

Targeted therapy. These medicines go after substances that help cancer cells grow and survive. They’re designed to kill cancer without harming healthy cells. Bevacizumab (Avastin) is another ...